SARP3 activators, as described here, encompass a diverse range of chemical compounds that indirectly influence the activity of the SARP3 protein through various cellular mechanisms and signaling pathways. These activators function by modulating different aspects of cellular signaling that ultimately converge on pathways involving SARP3. For example, compounds like Forskolin, IBMX, and Epinephrine operate primarily through the modulation of cAMP levels, a crucial secondary messenger in cellular signaling. By elevating cAMP, these compounds indirectly affect the cellular milieu in which SARP3 operates, leading to its activation. Similarly, Rolipram, by inhibiting phosphodiesterase 4, increases cAMP levels, echoing a similar mechanism of indirect activation of SARP3.
On the other hand, chemicals like Lithium Carbonate, PD98059, U0126, SB203580, and LY294002 target different aspects of intracellular signaling pathways, such as the MAPK/ERK pathway, PI3K/AKT signaling, and p38 MAP kinase activity. By influencing these pathways, they create a cellular environment that is conducive to the activation of SARP3. Rapamycin, with its role in inhibiting mTOR, also contributes to this category by affecting a wide array of cellular processes, including those related to SARP3 activity. Additionally, natural compounds like Resveratrol and Curcumin offer another dimension of SARP3 activation. These compounds are known to modulate various signaling pathways, including sirtuin and NF-kB pathways, which can indirectly impact the functioning of SARP3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels which can influence pathways involving SARP3. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective inhibitor of phosphodiesterases, elevating cAMP and cGMP levels, indirectly influencing SARP3. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Stimulates adrenergic receptors, leading to increased cAMP, affecting pathways linked with SARP3. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective PDE4 inhibitor, increasing cAMP levels in cells, indirectly impacting SARP3 activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Alters intracellular signaling pathways like GSK-3 inhibition, potentially affecting SARP3 activity. | ||||||